(1) Avanzini G and Franceschetti S. Cellular biology of epileptogenesis. Lancet. Neurol.(2003) 2:33-42.
(2) Banerjee PN, Filippi D and Allen Hauser W. The descriptive epidemiology of epilepsy-a review. Epilepsy res.(2009) 85:31-45.
(3) Laxer KD, Trinka E, and Hirsch L. The consequences of refractory epilepsy and its treatment. Epilepsy Behav.(2014) 37:59–70.
(4) Sakurai T, Amemiya A and Ishii M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G proteincoupled receptors that regulate feeding behavior. Cell (1998) 92:573-85.
(5) Chiou LC, Lee HJ, Ho YC, Chen SP, Liao YY, Ma CH, et al. Orexins/hypocretins: pain regulation and cellular actions. Curr. Pharm. Des. (2010) 16:3089-100.
(6) Razavi BM and Hosseinzadeh H. A review of the role of orexin system in pain modulation. Biomed. Pharmacother. (2017) 90:187-93.
(7) Ni L, Zhu M, Song Y, Liu Z and Tang J. Pentylenetetrazol-induced seizures are exacerbated by sleep deprivation through orexin receptor-mediated hippocampal cell proliferation. Neurol. Sci. (2014) 35:245–52.
(8) Ida T, Nakahara K, Katayama T, Murakami N and Nakazato M. Effect of lateral cerebroventricular injection of the appetitestimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats. Brain Res.(1999) 821:526–9.
(9) Erken HA, Erken G, and Genc O. Orexins cause epileptic activity. Peptides.(2012) 37:161–4.
(10) Kortunay S, Erken H, Erken G, Genç O, Şahiner M, Turgut S, et al. Orexins increase penicillin-induced epileptic activity. Peptides.(2012) 34:419-22.
(11) Goudarzi E, Elahdadi Salmani M, Lashkarbolouki Tand Goudarzi I. Hippocampal orexin receptors inactivation reduces PTZ induced seizures of male rats. Pharmacol.Biochem. Behav.(2015) 130:77-83.
(12) Hayatdavoudi P, Sadeghnia HR, Mohamadian-Roshan N and Hadjzadeh MA. Beneficial Effects of Selective Orexin-A Receptor Antagonist in 4-aminopyridine-induced Seizures in Male Rats. Adv. Biomed. Res. (2017) 6:162.
(13) Christopher JA. Small-molecule antagonists of the orexin receptors. Pharm. Pat.anal.(2014) 3:625-38.
(14) Zolfagharian F, Razavi BM and Hosseinzadeh H. Anticonvulsant effect of Satureja hortensis aerial parts extracts in mice. Avicenna j. phytomed.(2016) 6:305-12.
(15) Winrow CJ, Gotter AL, Cox CD, Doran SM, Tannenbaum PL, Breslin MJ, et al. Promotion of sleep by suvorexant-a novel dual orexin receptor antagonist. J. Neurogen.(2011) 25:52-61.
(16) Hosseinzadeh Hand Sadeghnia H. Protective effect of safranal on pentylenetetrazol-induced seizures in the rat: Involvement of GABAergic and opioids systems. Phytomedicine. (2007) 14:256-62.
(17) Boss Cand Roch C. Recent trends in orexin research—2010 to 2015. Bioorg. Med. Chem. Lett.(2015) 25:2875-87.
(18) Rejdak K, Papuc E, Grieb P and Stelmasiak Z. Decreased cerebrospinal fluid hypocretin-1 (orexin A) in patients after repetitive generalized tonic–clonic seizures. Epilepsia.(2009) 50:1641–4.
(19) Kordi Jaz E, Moghimi A, Fereidoni M, Asadi S, Shamsizadeh A and Roohbakhsh A. SB-334867, an orexin receptor 1 antagonist, decreased seizure and anxiety in pentylenetetrazol-kindled rats. Fund.clin. pharmacol.(2017) 31:201-7.
(20) Asadi S, Roohbakhsh A, Shamsizadeh A, Fereidoni M, Kordijaz E and Moghimi A. The effect of intracerebroventricular administration of orexin receptor type 2 antagonist on pentylenetetrazol-induced kindled seizures and anxiety in rats. BMC neurosci. (2018) 19:49.
(21) Selbach O, Doreulee N, Bohla C, Eriksson KS, Sergeeva OA, Poelchen W, et al. Orexins/hypocretins cause sharp wave- and theta-related synaptic plasticity in the hippocampus via glutamatergic, gabaergic, noradrenergic, and cholinergic signaling. Neuroscience.(2004) 127:519-28.
(22) Akbari N, Salmani M, Goudarzvand M, LashkarBoluki T, Goudarzi I and Akbari K. Unilateral hypothalamus inactivation prevents PTZ kindling development through hippocampal orexin receptor 1 modulation. Basic Clin. Neurosci. (2014) 5:66–73.
(23) Kodama T and Kimura M. Arousal effects of orexin-A correlate with GLU release from the locus coeruleus in rats. Peptides.(2002) 23:1673–81.